Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Single Center, Double-Blind, Randomized, Double Dummy, Placebo-Controlled, Three-Period Crossover Study to Assess the Effects of a mGluR2/3 Positive Allosteric Modulator [AZD8529] Upon Ketamine-Induced Cortical Stimulation and Impairment of Working-Memory Related Activation of the Prefrontal Cortex


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00985933

Organisation Name: AstraZeneca

Overal Status: Completed

Start Date: February 2010

Last Update: May 4, 2011

Lead Sponsor: AstraZeneca

Brief Summary: The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).

Conditions:
  • Healthy
  • Memory Impairment


Total execution time in seconds: 2.7673418521881